bupranolol has been researched along with cl 316243 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlan, M; Bousquet-Melou, A; Galitzky, J; Lafontan, M; Montastruc, JL | 1 |
| Atef, N; Doublé, A; Hélary, C; Ktorza, A; Lafontan, M; Pénicaud, L | 1 |
| Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD | 1 |
| Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M | 1 |
| Erfanian, M; Gauthier, C; Heymann, MF; Langin, D; Laurent, K; Tavernier, G; Toumaniantz, G | 1 |
| Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F | 1 |
| Clouse, AK; Hieble, JP; Riedel, E; Westfall, TD | 1 |
7 other study(ies) available for bupranolol and cl 316243
| Article | Year |
|---|---|
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bupranolol; Dioxoles; Dogs; Ethanolamines; Heart Rate; Isoproterenol; Male; Nitroprusside; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow; Skin | 1994 |
A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Female; Insulin; Insulin Secretion; Islets of Langerhans; Nadolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow | 1996 |
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine | 1999 |
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity | 1999 |
beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Bupranolol; Cyclic GMP; Depression, Chemical; Dioxoles; Electrocardiography; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Nadolol; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes | 2003 |
Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Ethanolamines; In Vitro Techniques; Ligands; Male; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; Vasodilation | 2005 |
The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Dose-Response Relationship, Drug; Ethanolamines; Female; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Myometrium; Oxytocics; Oxytocin; Potassium Chloride; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Ritodrine; Urinary Bladder; Uterine Contraction | 2007 |